255 related items for PubMed ID: 9874317
21. Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome.
Aizawa-Yashiro T, Tsuruga K, Watanabe S, Oki E, Ito E, Tanaka H.
Pediatr Nephrol; 2011 Aug; 26(8):1255-61. PubMed ID: 21479767
[Abstract] [Full Text] [Related]
22. Comparison between pre- and posttreatment clinical and renal biopsies in children receiving low dose ciclosporine-A for 2 years for steroid-dependent nephrotic syndrome.
Kano K, Kyo K, Yamada Y, Ito S, Ando T, Arisaka O.
Clin Nephrol; 1999 Jul; 52(1):19-24. PubMed ID: 10442491
[Abstract] [Full Text] [Related]
23. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J, Ehrich JH, Querfeld U.
Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
[Abstract] [Full Text] [Related]
24. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J.
Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923
[Abstract] [Full Text] [Related]
25. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
Gulati S, Prasad N, Sharma RK, Kumar A, Gupta A, Baburaj VP.
Nephrol Dial Transplant; 2008 Mar; 23(3):910-3. PubMed ID: 18039644
[Abstract] [Full Text] [Related]
26. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[Abstract] [Full Text] [Related]
27. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.
Büscher AK, Kranz B, Büscher R, Hildebrandt F, Dworniczak B, Pennekamp P, Kuwertz-Bröking E, Wingen AM, John U, Kemper M, Monnens L, Hoyer PF, Weber S, Konrad M.
Clin J Am Soc Nephrol; 2010 Nov; 5(11):2075-84. PubMed ID: 20798252
[Abstract] [Full Text] [Related]
28. Does cyclosporine achieve a real advantage for treatment of idiopathic nephrotic syndrome in children? A long-term efficacy and safety study.
Sheashaa H, Mahmoud I, El-Basuony F, El-Husseini A, Hassan N, El-Baz M, Ahmed NS, Sobh M.
Int Urol Nephrol; 2007 Nov; 39(3):923-8. PubMed ID: 17447154
[Abstract] [Full Text] [Related]
29. Correlation of fractional excretion of magnesium with steroid responsiveness in children with nephrotic syndrome.
Rumana J, Hanif M, Muinuddin G, Maruf-Ul-Quader M.
Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):830-6. PubMed ID: 24969196
[Abstract] [Full Text] [Related]
30. Follow-up of steroid-resistant nephrotic syndrome: tubular proteinuria and enzymuria.
Vallés P, Peralta M, Carrizo L, Martin L, Principi I, Gonzalez A, Manucha W.
Pediatr Nephrol; 2000 Dec; 15(3-4):252-8. PubMed ID: 11149121
[Abstract] [Full Text] [Related]
31. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie.
Meyrier A, Noël LH, Auriche P, Callard P.
Kidney Int; 1994 May; 45(5):1446-56. PubMed ID: 8072258
[Abstract] [Full Text] [Related]
32. Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome.
El-Husseini A, El-Basuony F, Mahmoud I, Donia A, Sheashaa H, Sabry A, Hassan N, Sayed-Ahmad N, Sobh M.
Eur J Clin Pharmacol; 2006 Jan; 62(1):3-8. PubMed ID: 16374637
[Abstract] [Full Text] [Related]
33. Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy.
Peña A, Bravo J, Melgosa M, Fernandez C, Meseguer C, Espinosa L, Alonso A, Picazo ML, Navarro M.
Pediatr Nephrol; 2007 Nov; 22(11):1875-80. PubMed ID: 17876609
[Abstract] [Full Text] [Related]
34. A clinicopathologic study of primary focal segmental glomerulosclerosis in children.
Lanewala A, Mubarak M, Kazi JI, Akhter F, Sher A, Fayyaz A, Bhatti S.
Saudi J Kidney Dis Transpl; 2012 May; 23(3):513-20. PubMed ID: 22569437
[Abstract] [Full Text] [Related]
35. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children.
Inaba A, Hamasaki Y, Ishikura K, Hamada R, Sakai T, Hataya H, Komaki F, Kaneko T, Mori M, Honda M.
Pediatr Nephrol; 2016 Mar; 31(3):425-34. PubMed ID: 26335197
[Abstract] [Full Text] [Related]
36. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
Chishti AS, Sorof JM, Brewer ED, Kale AS.
Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878
[Abstract] [Full Text] [Related]
37. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T.
Clin Nephrol; 2009 Oct; 72(4):268-73. PubMed ID: 19825332
[Abstract] [Full Text] [Related]
38. Nephrotic syndrome in Namibian children.
van Buuren AJ, Bates WD, Muller N.
S Afr Med J; 1999 Oct; 89(10):1088-91. PubMed ID: 10582066
[Abstract] [Full Text] [Related]
39. Treatment of idiopathic nephrotic syndrome with cyclosporine A.
Meyrier A.
J Nephrol; 1997 Oct; 10(1):14-24. PubMed ID: 9241620
[Abstract] [Full Text] [Related]
40. Epidemiology of primary nephrotic syndrome in Egyptian children.
Kaddah A, Sabry S, Emil E, El-Refaey M.
J Nephrol; 2012 Oct; 25(5):732-7. PubMed ID: 22101675
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
